When Stephanie Bryant and Karin Payne submitted a $125,000 collaborative proposal for seed funding from the new AB Nexus initiative in 2020, they couldn’t imagine that only a few years later the ...

Today, the AB Nexus program announced its 2024 seed grant awards to interdisciplinary research teams from the University of Colorado Anschutz Medical Campus and the University of Colorado Boulder.

PRESS RELEASEAB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER FORMALLY GRANTED IN THE UNITED ...

As part of a collaborative research agreement with the University of Chicago, AB Science signed an exclusive licensing agreement to conduct research for the prevention and treatment of COVID-19 with ...

Good morning, and good afternoon for the participant to our web conference organized by AB Science. About an update of the clinical development of our asset called AB8939. My name is Alain Moussy, I'm ...

(RTTNews) - French pharmaceutical company AB Science SA (ABSCF.PK) announced Monday that it has received Chinese patent protecting Masitinib in the treatment of Covid-19 until April 2041. In Paris, AB ...

Masitinib treatment has been linked to a 5-year survival rate of 42.3% from the onset of the disease, marking a two-fold increase compared to historical standards. In patients with ALS who had not ...

STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE'S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE AB Science SA (Euronext - FR0010557264 - AB) announces that ...